NICE enough? Do NICE’s Decision Outcomes Impact International HTA Decision-making?
External Expert Profile
Anne R. Mason
Latest Publications
How is Quality of Life Measured for Health Technology Assessments?
Resource Allocation in Public Sector Programmes: Does the Value of a Life Differ Between Governmental Departments?
Using QALYs in Cancer: Review of the Methodological Limitations
Assessment and Appraisal of Oncology Medicines: NICE’s Approach and International HTA Experience
